FAIRFIELD, Iowa, March 17, 2014 — Hedge funds gained 2.00% in February, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 1.59% year to date.
“Improving investor sentiment fueled by robust M&A activity and strong corporate earnings helped most global equity markets rebound in February, with the exception of China, Japan, and Russia,” says Sol Waksman, founder and president of BarclayHedge.
For the second straight month, the Barclay Healthcare & Biotechnology Index led the way with a 5.01% gain, and is up 11.19% after two months of trading in 2014.
“Year to date, the healthcare equity sector of the MSCI World Index is its top performing sector with a gain of 7.3 percent,” says Waksman.
The Technology Index was up 3.24% in February, the Event Driven Index was up 2.91%, Equity Long Bias gained 2.91%, Distressed Securities were up 3.04%, and European Equities added 2.59%.
The Equity Short Bias Index was hit hard in February, losing 3.87% for the month. The Global Macro Index was down 0.30%.
The Barclay Fund of Funds Index gained 1.66% in February, and now has a positive return of 1.40% for the year.
Click here to view five years of Barclay Hedge Fund Index data or download 17 years of monthly data.
Sol Waksman is an experienced media source, providing perspectives on hedge fund and managed futures trends. For more commentary or background, call 641-472-3456 or email swaksman@barclayhedge.com.
BarclayHedge was founded in 1985 and actively tracks more than 6,200 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories, 16 CTA categories, and 7 UCITS categories.
Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.